antibodies anti c3ar antibody (Santa Cruz Biotechnology)
Structured Review
Antibodies Anti C3ar Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies anti c3ar antibody/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice"
Article Title: Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice
Journal: BMC Cardiovascular Disorders
doi: 10.1186/s12872-024-04077-6
Figure Legend Snippet: Expression of C3aR was upregulated in the aorta of MFS mice. (A) the mRNA levels of C3aR in 3-month-old WT and FBN1 C1041G/+ aortas were accessed by qRT-PCR ( n = 4 per group). (B , C) IHC staining for C3aR in the aortas of 3-month-old WT and FBN1 C1041G/+ mice ( n = 6 per group). ** P < 0.01, vs. the WT group. (D) the mRNA levels of Il1b , Ccl2 , Ccl5 , Spp1 in PBS, recombinant C3a (1ug/mL) stimulated macrophages were accessed by qRT-PCR. ( n = 4 per group). (E , F) CBA assay was used to detect the concentration of IL-1β (E) and CCL2 (F) in culture medium of PBS or recombinant C3a stimulated macrophages. ( n = 4 per group). The data were analyzed using the nonparametric Kruskal-Wallis H test. * P < 0.05, ** P < 0.01, vs. PBS group
Techniques Used: Expressing, Quantitative RT-PCR, Immunohistochemistry, Recombinant, Concentration Assay
Figure Legend Snippet: C3aR antagonist (C3aRA) reduces aortic dilatation and elastic fiber rupture of MFS mice. (A) (B-C) Representative images of ultrasound images of the ascending aortas ( B ) and abdominal aortas ( C ) of WT, MFS controls and C3aRA treated MFS mice. (D-E) The diameters of ascending aortas (AsAo) and abdominal aortas (AbAo) ( n = 6 per group). (F) Representative images of EVG elastic fiber staining of ascending aortic section from WT, MFS controls and C3aRA treated MFS mice. Scale bar, 50 μm. (G-H) Quantification of aortic medial thickness (G) and elastic fiber breaks (H) in the ascending aortic sections ( n = 6 per group). The data were analyzed using the nonparametric Kruskal-Wallis H test. ** P < 0.01 vs. WT group; ++ P < 0.01 vs. MFS PBS group
Techniques Used: Staining
Figure Legend Snippet: Schematic illustration of the C3a-C3aR pathway contributing to the formation of aortic aneurysm in MFS mice
Techniques Used:
anti c3ar (Thermo Fisher)
Thermo Fisher is a verified supplier
Thermo Fisher manufactures this product
Structured Review
Anti C3ar, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti c3ar/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
anti c3ar1 (Bioss)
Bioss is a verified supplier
Bioss manufactures this product
Structured Review
Anti C3ar1, supplied by Bioss, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti c3ar1/product/Bioss
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome"
Article Title: Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome
Journal: Biomedicines
doi: 10.3390/biomedicines12071513
Figure Legend Snippet: The hub genes detection form NRGs and DEGs from Target-OS. ( A ) The Venn diagram illustrates the presence of 24 differentially expressed genes (DEGs) resulting from the overlap between 538 neutrophil-related genes (NRGs) and 161 up-regulated DEG mRNAs from Target-OS. ( B ) The most significant candidate genes were identified through the implementation of univariate Cox regression analyses. ( C ) Prognostic signature genes were selected based on their association with survival outcomes, as demonstrated by Kaplan–Meier (KM) survival curves in Target-OS. ( D , E ) The LASSO algorithm was employed to select hub genes. ( F ) The LASSO algorithm identified two genes, namely C3AR1 and FCER1G, as significant.
Techniques Used:
Figure Legend Snippet: ESTIMATE evaluation based on the two hub genes. ( A – H ) In both the TARGET-OS and GSE21257 cohorts, a comparison was made between high and low samples regarding the stromal scores, immune scores, ESTIMATE scores, and tumor purity. Additionally, it was observed that C3AR1 or FCER1G exhibited a significant positive correlation with stromal scores, ESTIMATE scores, and immune scores, while displaying a strong negative correlation with tumor purity in both cohorts. ** p < 0.01, ****: p < 0.0001.
Techniques Used: Comparison
Figure Legend Snippet: Evaluation of immunomodulators based on the two hub genes. ( A , B ) Heatmap displaying enrichment of immunomodulators through 7 algorithms between high- and low groups according to C3AR1 and FCER1G levels in the TARGET-OS ( A ) and GSE21257 cohorts ( B ). ns: p > 0.05; * p < 0.05, ** p < 0.01, *** p < 0.001.
Techniques Used:
Figure Legend Snippet: FCER1G/C3AR1 correlated KEGG NSP in OS. ( A ) The correlation between FCER1G and KEGG NSP genes was examined in the TARGET-OS dataset. ( B ) The correlation between FCER1G and KEGG NSP scores was investigated in the TARGET-OS dataset. ( C ) A comparison was made between the KEGG NSP scores in subgroups with high and low FCER1G expression in the TARGET-OS dataset. ( D ) The expression of FCER1G was compared between subgroups with high and low KEGG NSP scores in the TARGET-OS dataset. ( E ) The correlation between FCER1G and KEGG NSP genes was examined in the GSE21257 dataset. ( F ) The correlation between FCER1G and KEGG NSP scores was investigated in the GSE21257 dataset. ( G ) A comparison was made between the KEGG NSP scores in subgroups with high and low FCER1G expression in the GSE21257 dataset. ( H ) The expression of FCER1G was compared between subgroups with high and low KEGG NSP scores in the GSE21257 dataset. ( I ) The correlation between C3AR1 and KEGG NSP genes was examined in the TARGET-OS dataset. ( J ) The correlation between C3AR1 and KEGG NSP scores was investigated in the TARGET-OS dataset. ( K ) A comparison was made between the KEGG NSP scores in subgroups with high and low C3AR1 expression in the TARGET-OS dataset. ( L ) The expression of C3AR1 was compared between subgroups with high and low KEGG NSP scores in the TARGET-OS dataset. ( M ) The correlation between C3AR1 and KEGG NSP genes was examined in the GSE21257 dataset. ( N ) The correlation between C3AR1 and KEGG NSP scores was investigated in the GSE21257 dataset. ( O ) A comparison was made between the KEGG NSP scores in subgroups with high and low C3AR1 expression in the GSE21257 dataset. ( P ) The expression of C3AR1 was compared between subgroups with high and low KEGG NSP scores in the GSE21257 dataset. ****: p < 0.0001.
Techniques Used: Comparison, Expressing
Figure Legend Snippet: SPI1 was identified as a potential key TF in OS. ( A ) The heatmap illustrates the identification of 18 transcription factors (TFs) using the DoRothEA R package in scRNA-seq data. ( B ) The volcano plot generated from the analysis of scRNA-seq data reveals the presence of eight differentially expressed genes (DEGs) that exhibit significant differences between aneuploid and diploid groups. ( C , D ) The identification of potential transcription factors (TFs) that may regulate the C3AR1 and FCER1G genes involves screening two databases (JASPAR and ChEA) through the utilization of NetworkAnalyst 3.0. ( E – H ) The expression levels of SPI1 and RUNX1 were found to be decreased in both the TARGET-OS and GSE21257 datasets. ( I – L ) The Kaplan–Meier survival plots demonstrate the overall survival (OS) of the SPI1 and RUNX1 genes in both the TARGET-OS and GSE21257 datasets.
Techniques Used: Generated, Expressing
Figure Legend Snippet: Evaluation of C3AR1, FCER1G and SPI1 in OS animal model. ( A – C ) The three genes (C3AR1 ( A ), FCER1G ( B ) and SPI1 ( C )) showed significant upregulation in OS mice tissue samples compared to normal tissue samples. ( D , E ) Correlation circle pipes and light image show the correlations among C3AR1, FCER1G and SPI1 genes in OS mice tissues. ( F ) The potential transcription factor regulatory network in OS was investigated. Data were represented as mean with SD.
Techniques Used: Animal Model
Figure Legend Snippet: IHC for C3AR1, FCER1G and SPI1. ( A – C ) IHC for C3AR1, FCER1G, and SPI1 in the normal tissue samples (20× magnification). ( D – F ) IHC for C3AR1, FCER1G and SPI1 in the OS mice tissues (20× magnification). ( G – I ) The violin plots exhibit higher levels of staining for C3AR1, FCER1G and SPI1 protein expression in OS tissues as compared to normal tissue samples. AOD = Average optical density. * p < 0.05.
Techniques Used: Staining, Expressing
anti c3ar antibody (Danaher Inc)
Danaher Inc is a verified supplier
Danaher Inc manufactures this product
Structured Review
Anti C3ar Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti c3ar antibody/product/Danaher Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease"
Article Title: Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease
Journal: Clinical and Experimental Medicine
doi: 10.1007/s10238-024-01410-3
Figure Legend Snippet: Immunohistochemical staining suggests increased expression of C3a, C3aR, C5a, C5aR in advanced IgAN (× 400), with significant differences between ESRD and non-ESRD groups. AOD, average optical density. * P < 0.05, ** P < 0.01, *** P < 0.001
Techniques Used: Immunohistochemical staining, Staining, Expressing
Figure Legend Snippet: Spearman correlation analysis between C3a/C3aR, C5a/C5aR and baseline eGFR, baseline 24 h-UP, ΔeGFR/M. The results suggested that C3a ( A , r = − 0.58, P < 0.001), C3aR ( D , r = − 0.36, P = 0.002), C5a ( G , r = − 0.59, P < 0.001) and C5aR ( J , r = − 0.35, P = 0.003) were all negatively correlated with baseline eGFR, while positively with baseline 24 h-UP ( B , E , H , K ). Deposits of C3a/C3aR and C5a/C5aR could accelerate the mean rate of renal function decline ( C , F , I , L )
Techniques Used:
mouse anti c3ar (Santa Cruz Biotechnology)
Structured Review
Mouse Anti C3ar, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti c3ar/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
mouse anti c3ar (Santa Cruz Biotechnology)
Structured Review
Mouse Anti C3ar, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti c3ar/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
rabbit anti c3ar antibody (Wuhan Sanying Biotechnology)
Structured Review
Rabbit Anti C3ar Antibody, supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti c3ar antibody/product/Wuhan Sanying Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats"
Article Title: Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats
Journal: Frontiers in Pharmacology
doi: 10.3389/fphar.2024.1384418
Figure Legend Snippet: Effect of MG on the complement system. RGC, retinal ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelial layer; * model vs. normal; # anti-VEGF/MG + anti-VEGF vs. model; and &MG + anti-VEGF vs. anti-VEGF; data are represented as mean ± SD; immunofluorescence: n = 5; qRT-PCR: n = 3. (A) Image of immunofluorescence staining, rows represent different factors, and columns represent different groups. (B) Immunofluorescence expression levels of C3aR: * p = 0.000, # p = 0.000 (anti-VEGF) and p = 0.000 (MG + anti-VEGF), & p = 0.015; expression levels of (C) C3aR mRNA: * p = 0.004, # p = 0.014 (MG + anti-VEGF); and (D) C3a mRNA: * p = 0.000, # p = 0.002 (anti-VEGF) and p = 0.000 (MG + anti-VEGF), & p = 0.000.
Techniques Used: Immunofluorescence, Quantitative RT-PCR, Staining, Expressing
c3ar (Santa Cruz Biotechnology)
Structured Review
C3ar, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c3ar/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging"
Article Title: Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging
Journal: Journal of Neuroinflammation
doi: 10.1186/s12974-024-03130-7
Figure Legend Snippet: Altered expression of complement pathway components by old hippocampal microglia, especially in females. ( a ) Complement System pathway identified by performing IPA analysis of old versus young female, old versus young male, and old female versus old male microglia. Dashed line: -log 10 (p-value) cutoff of 1.3 ( p < 0.05). ( b ) Expression of the complement pathway genes C3 , C3ar1 , Cd55 and Ctsl . Data are presented as mean (SD) FPKM values. n = 5/group. ( c ) Complement gene expression by homeostatic (young and old) microglia and old DAM . Dot size shows the percentage of cells expressing the genes, and the color intensity scale indicates average gene expression by all cells in the cluster. ( d , e ) Complement gene expression by WT and 5XFAD homeostatic microglia and 5XFAD DAM from male and female mice (1 male and 2 females; d ), and homeostatic microglia and DAM1 and DAM2 subsets (1 male and 2 females combined; e ) . ( f , g ) C3aR protein expression in the hippocampus of young and old, male and female mice. Representative immunoblot images ( f ; arrow: C3aR band) and quantification of C3aR expression ( g ) are shown. n = 5/group. Data are presented as mean (SD). ( h ) C3aR expression by microglia (Iba-1 + ) in the hippocampus. Quantification of C3aR/Iba-1 colocalization (% of YF) is shown. n = 4/group. Data are presented as mean (SD). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (two-way ANOVA); # p < 0.05, ## p < 0.01 (unpaired t-test)
Techniques Used: Expressing, Western Blot
Figure Legend Snippet: Microglial C3a – C3aR signaling promotes glycolysis and phagocytosis. Young microglia (postnatal day 0–2) were treated with 10 nM recombinant mouse C3a. ( a - d ) p-AKT (Ser473), p-mTOR (Ser2448) and HIF1α were assessed by Western blotting at the indicated timepoints (0–24 h), and expression was normalized to total AKT, total mTOR and β-actin, respectively. n = 5 replicates. Data are presented as mean (SEM). * p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA). ( e - g ) Seahorse assays were used to evaluate real-time glycolytic rate in young microglia (postnatal day 0–2, pooled male and female) after 18 h in vitro treatment with 10 nM recombinant mouse C3a. Stimuli were added as indicated ( e ), and basal glycolysis ( f ) and compensatory glycolysis ( g ) were determined by calculating the glycolytic Proton Efflux Rate (e; glycoPER). n = 5/group. # p < 0.05 (unpaired t-test). ( h , i ) Flow cytometry analysis was performed to assess phagocytosis of FITC-fAβ 1−42 . Rapamycin (50 µM) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a. Proportion of phagocytic cells ( h ) was assessed by evaluating FITC-positive microglia, and FITC MFI was evaluated in total live microglia ( i ). Data are presented as mean (SEM). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (one-way ANOVA)
Techniques Used: Recombinant, Western Blot, Expressing, In Vitro, Flow Cytometry
anti c3ar (Santa Cruz Biotechnology)
Structured Review
Anti C3ar, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti c3ar/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging"
Article Title: Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging
Journal: Journal of Neuroinflammation
doi: 10.1186/s12974-024-03130-7
Figure Legend Snippet: Altered expression of complement pathway components by old hippocampal microglia, especially in females. ( a ) Complement System pathway identified by performing IPA analysis of old versus young female, old versus young male, and old female versus old male microglia. Dashed line: -log 10 (p-value) cutoff of 1.3 ( p < 0.05). ( b ) Expression of the complement pathway genes C3 , C3ar1 , Cd55 and Ctsl . Data are presented as mean (SD) FPKM values. n = 5/group. ( c ) Complement gene expression by homeostatic (young and old) microglia and old DAM . Dot size shows the percentage of cells expressing the genes, and the color intensity scale indicates average gene expression by all cells in the cluster. ( d , e ) Complement gene expression by WT and 5XFAD homeostatic microglia and 5XFAD DAM from male and female mice (1 male and 2 females; d ), and homeostatic microglia and DAM1 and DAM2 subsets (1 male and 2 females combined; e ) . ( f , g ) C3aR protein expression in the hippocampus of young and old, male and female mice. Representative immunoblot images ( f ; arrow: C3aR band) and quantification of C3aR expression ( g ) are shown. n = 5/group. Data are presented as mean (SD). ( h ) C3aR expression by microglia (Iba-1 + ) in the hippocampus. Quantification of C3aR/Iba-1 colocalization (% of YF) is shown. n = 4/group. Data are presented as mean (SD). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (two-way ANOVA); # p < 0.05, ## p < 0.01 (unpaired t-test)
Techniques Used: Expressing, Western Blot
Figure Legend Snippet: Microglial C3a – C3aR signaling promotes glycolysis and phagocytosis. Young microglia (postnatal day 0–2) were treated with 10 nM recombinant mouse C3a. ( a - d ) p-AKT (Ser473), p-mTOR (Ser2448) and HIF1α were assessed by Western blotting at the indicated timepoints (0–24 h), and expression was normalized to total AKT, total mTOR and β-actin, respectively. n = 5 replicates. Data are presented as mean (SEM). * p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA). ( e - g ) Seahorse assays were used to evaluate real-time glycolytic rate in young microglia (postnatal day 0–2, pooled male and female) after 18 h in vitro treatment with 10 nM recombinant mouse C3a. Stimuli were added as indicated ( e ), and basal glycolysis ( f ) and compensatory glycolysis ( g ) were determined by calculating the glycolytic Proton Efflux Rate (e; glycoPER). n = 5/group. # p < 0.05 (unpaired t-test). ( h , i ) Flow cytometry analysis was performed to assess phagocytosis of FITC-fAβ 1−42 . Rapamycin (50 µM) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a. Proportion of phagocytic cells ( h ) was assessed by evaluating FITC-positive microglia, and FITC MFI was evaluated in total live microglia ( i ). Data are presented as mean (SEM). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (one-way ANOVA)
Techniques Used: Recombinant, Western Blot, Expressing, In Vitro, Flow Cytometry
c3ar (Cell Signaling Technology Inc)
Cell Signaling Technology Inc manufactures this product
Structured Review
C3ar, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c3ar/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99